Managing Ulcerative Colitis – The Guidelines and Beyond
Management guidelines offer clinicians clear, evidence-based and often succinct treatment advice. For ulcerative colitis these guidelines describe the use of 5-ASA, corticosteroids, thiopurines, cyclosporine, and anti-TNFα therapies. However, guidelines do have some drawbacks, mainly a lack of concr...
Main Authors: | Mitchell RKL Lie, C Janneke van der Woude |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2013-11-01
|
Series: | European Medical Journal Gastroenterology |
Subjects: | |
Online Access: | http://emjreviews.com/wp-content/uploads/Managing-Ulcerative-Colitis-The-Guidelines-and-Beyond.pdf |
Similar Items
-
BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS
by: E. A. Pyadushkina
Published: (2017-05-01) -
Golimumab Therapy in Ulcerative Colitis
by: Won Moon
Published: (2016-02-01) -
Development of new methodology for therapeutic drug monitoringof thiopurine treatment
by: Vikingsson, Svante
Published: (2012) -
Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis
by: M. Galván-Banqueri, et al.
Published: (2015-01-01) -
Alternative treatment regimens in autoimmune hepatitis: how justified is their choice?
by: M. V. Matsievich, et al.
Published: (2018-11-01)